Gastric Cancer Risk Factors Knowledge in European and Latinamerican Population

Completed

• Conditions: Gastric Cancer

• Registration Number: NCT04019808
• Lead Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia

Brief Summary

This study is divided into two parts:

Part 1: An interventional study, with a pre-post study design to determinate the grade of knowledge of established GC risk factors.

Part 2: An observational study to know impact on prevalence and infection eradication of H. pylori

Detailed Description

Part 1: to determinate the grade of knowledge of established GC risk factors and identification of attitudes about, GC screening programs at baseline, prior to the intervention though an educational program.

Part 2: to generate an H. pylori registry, to know its impact on prevalence and infection eradication rate at 6th, 12th, 24th and at Month 36th.

Study Timeline

• Study First Submitted: 2019-06-05
• Study First Submitted QC: 2019-07-12
• Study First Posted: 2019-07-15
• Study Start: 2019-07-30
• Primary Completion: 2023-12-31
• Study Completion: 2023-12-31
• Status Verified: 2024-05
• Last Update Submitted: 2024-05-08
• Last Update Posted: 2024-05-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 800

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
knowledge GC risk factors and symptoms	3 years	Compare the results obtained through a knowledge of CG risk factors by study-specific questionnaire before and after an educational intervention
H. pylori prevalence and drug resistance	3 years	Generate an H. pylori registry, to know its impact on prevalence and infection eradication rate at months 6th, 12th, 24th and 36th.

Trial Locations

Locations (8)

Pontificia Universidad Católica de Chile; 🇨🇱 Santiago, Chile

Instituto Alexander Fleming; 🇦🇷 Buenos Aires, Argentina

Instituto Nacional de Cancerología; 🇲🇽 Mexico, Mexico

VU Medical Centre; 🇳🇱 Amsterdam, Netherlands

GenPat; 🇵🇾 Asunción, Paraguay

Fundació Privada Institut d'Investigació Oncològica de Vall-Hebron (VHIO); 🇪🇸 Barcelona, Spain

Institute of Pathology and Immunology of University of Porto; 🇵🇹 Porto, Portugal

Fundación Investigación Clínico de Valencia; 🇪🇸 Valencia, Spain